JBCHEPHARM.BOJBCHEPHARM.BOBSE
Loading
Operating Cash Flow Growth Under PressureDecelerating
Percentile Rank43
5Y CAGR-21.5%
Studio
Year-over-Year Change

Year-over-year operating cash flow growth rate

5Y CAGR
-21.5%/yr
Long-term compound
Percentile
P43
Within normal range
vs 5Y Ago
0.3x
Contraction
Streak
2 yr
Consecutive declineDecelerating
PeriodValue
202512.72%
202427.97%
2023267.71%
2022-45.95%
202114.31%
202042.62%
201956.91%
2018-38.54%
201743.34%
201610.26%